Over the past few decades, cardiovascular disease and diabetes have emerged as major public health problems, both as distinct clinical entities and as comorbid conditions. As a result, the fields of vascular biology and endocrinology are working more closely now than ever before. With chapters by renowned experts, Cardiovascular Endocrinology: Shared Pathways and Clinical Crossroads emphasizes the considerable physiological interrelationships and clinical correlations between the specialties of cardiovascular medicine and endocrinology.
Offering a wealth of information, Cardiovascular Endocrinology: Shared Pathways and Clinical Crossroads provides a range of insights, including a novel view of the hormonal regulation of the vascular system and the disruption of the nitric oxide signaling system. It also addresses the role of fatty acids and cytokines in the development of this problem. Importantly, this unique title also provides a state-of-the-art update on the importance of other hormones such as thyroid hormone and steroids, as well as the pathophysiology of cardiovascular disease and controversies surrounding the use of hormone replacement therapy.
In all, Cardiovascular Endocrinology: Shared Pathways and Clinical Crossroads is a first-of-its-kind title that discusses and summarizes important clinical topics in cardiology and endocrinology. It offers clinicians and researchers an important resource for navigating the increasingly interrelated pathways of cardiovascular and endocrinologic disorders. The authors discuss a range of important issues from epidemiology to bench research to translation of this research to clinical practice.
Author(s): Vivian Fonseca
Series: Contemporary Endocrinology
Edition: 1
Publisher: Humana Press
Year: 2008
Language: English
Pages: 255
Cardiovascular Endocrinology......Page 1
Cardiovascular Endocrinology......Page 2
Preface......Page 6
Contents......Page 7
Contributors......Page 9
01. Hormonal Regulation of the Vascular System: An Overview......Page 12
Part I. Diabetes and Cardiovascular Disease......Page 27
02. Epidemiology and Prevention of Cardiovascular Disease in Diabetes......Page 28
03. Disruption of the Nitric Oxide Signaling System in Diabetes......Page 43
04. Free Fatty Acids, A Major Link Between Obesity, Insulin Resistance, Inflammation, and Atherosclerotic Vascular Disease......Page 68
05. The Anti-Inflammatory and Antiatherogenic Effects of Insulin......Page 78
06. Insulin Sensitizers and Cardiovascular Disease......Page 87
07. Screening for Cardiovascular Disease in Symptomatic and Asymptomatic Patients with Diabetes Mellitus......Page 102
Part II. Endocrine Hypertension and Cardiovascular Events......Page 124
08. Renin-Angiotensin System......Page 125
09. Microalbuminuria and Chronic Kidney Disease as Cardiovascular Risk Factors......Page 152
Part III. Obesity in Cardiovascular Disease......Page 171
10. Adiponectin and Cardiovascular Disease......Page 172
Part IV. Sex Hormones and Vascular Disease......Page 186
11. Testosterone and Cardiovascular Disease......Page 187
12. Sexual Dysfunction and Cardiovascular Risk – Links and Solutions......Page 198
Part V. Of Interest......Page 215
13. Natriuretic Peptides and Cardiovascular Regulation......Page 216
14. Insulin-Like Growth Factors, Cardiovascular Risk Factors, and Cardiovascular Disease......Page 235
Index......Page 242